{"id":"at01","safety":{"commonSideEffects":[{"rate":"null","effect":"Increased risk of genital yeast infections"}]},"_chembl":{"chemblId":"CHEMBL5314633","moleculeType":"Protein"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"By inhibiting SGLT2, AT01 reduces glucose reabsorption in the kidneys, leading to decreased blood glucose levels. This mechanism is particularly useful for the treatment of type 2 diabetes.","oneSentence":"AT01 is a small molecule that targets the SGLT2 receptor.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T03:21:34.814Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Type 2 diabetes"}]},"trialDetails":[{"nctId":"NCT07494084","phase":"PHASE4","title":"Sleep Loss and Circadian Misalignment - Mechanisms of Insulin Resistance","status":"NOT_YET_RECRUITING","sponsor":"Washington State University","startDate":"2026-05-01","conditions":"Shift Work Schedule, Circadian Rhythm, Insulin Resistance","enrollment":24},{"nctId":"NCT06974877","phase":"PHASE1","title":"Repeat PET/CT Imaging in People With CAPS and Anakinra-Induced Amyloidosis Using an Amyloid-Reactive Peptide to Measure Changes in Organ-Specific Amyloid Load","status":"RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2025-09-10","conditions":"Cryopyrin-Associated Periodic Syndromes, Amyloidosis","enrollment":30},{"nctId":"NCT05758493","phase":"PHASE2","title":"Characterizing Iodine-124 Evuzumitide (AT-01) in Systemic Amyloidosis","status":"RECRUITING","sponsor":"Oregon Health and Science University","startDate":"2023-01-10","conditions":"Amyloidosis, Transthyretin Amyloidosis","enrollment":150},{"nctId":"NCT06788535","phase":"PHASE3","title":"Research With I-124 EVuzamitide to Elucidate Cardiac AmyLoidosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sharmila Dorbala","startDate":"2025-01-14","conditions":"Cardiac Amyloidosis","enrollment":200},{"nctId":"NCT07140536","phase":"NA","title":"The Impact of Treadmills and Cooler Environments for Office Workplaces on Ergonomics, Heating Energy Requirements, Performance, as Well as Back and Cardiometabolic Health","status":"COMPLETED","sponsor":"RWTH Aachen University","startDate":"2025-07-03","conditions":"Healthy Male and Female Subjects","enrollment":16},{"nctId":"NCT05235269","phase":"PHASE2","title":"A Study to Evaluate Organ Level Uptake Repeatability of 124I AT-01 in Subjects With Systemic Amyloidosis","status":"COMPLETED","sponsor":"Attralus, Inc.","startDate":"2021-11-30","conditions":"Amyloidosis","enrollment":33},{"nctId":"NCT07100002","phase":"NA","title":"Comparing the Efficacy of Earplugs and Eye Masks on Pain and Sleep Quality","status":"COMPLETED","sponsor":"Giresun University","startDate":"2024-01-01","conditions":"Sleep Quality, Pain, Intensive Care Medicine","enrollment":75},{"nctId":"NCT05635045","phase":"PHASE2","title":"Evuzamitide in PET/CT to Measure Potential Therapeutic Response in ATTR","status":"COMPLETED","sponsor":"Columbia University","startDate":"2022-07-08","conditions":"Transthyretin Amyloidosis","enrollment":10},{"nctId":"NCT06907849","phase":"PHASE2","title":"124I-Evuzamitide PET/CT Imaging In Patients With Lumbar Spinal Stenosis and Carpal Tunnel Syndrome","status":"ENROLLING_BY_INVITATION","sponsor":"University of Tennessee Graduate School of Medicine","startDate":"2025-05","conditions":"Lumbar Spinal Stenosis, Carpal Tunnel Syndrome (CTS), Cardiac Amyloidosis","enrollment":40},{"nctId":"NCT06809296","phase":"","title":"Assessment of the Effects of Acute Exposure to Cold and Heat on Appetite","status":"NOT_YET_RECRUITING","sponsor":"Direction Centrale du Service de Santé des Armées","startDate":"2025-02","conditions":"Appetite","enrollment":40},{"nctId":"NCT06781671","phase":"NA","title":"Use of Comfort Theory In Intensive Care","status":"COMPLETED","sponsor":"Sakarya University","startDate":"2019-10-23","conditions":"Intensive Care Unit","enrollment":50},{"nctId":"NCT05968846","phase":"PHASE2","title":"Repeat PET/CT Imaging of Patients With Amyloid 124I-AT-01 to Measure Changes in Organ-specific Amyloid Load","status":"COMPLETED","sponsor":"University of Tennessee Graduate School of Medicine","startDate":"2022-12-07","conditions":"Systemic Amyloidosis","enrollment":19},{"nctId":"NCT02778659","phase":"NA","title":"Hypnotic Intake and Motor and Cognitive Performances at High Altitude","status":"COMPLETED","sponsor":"Centre d'Expertise sur l'Altitude EXALT","startDate":"2016-05","conditions":"Physiology","enrollment":22},{"nctId":"NCT00788229","phase":"PHASE2","title":"Efficacy and Safety Study of ATs in Patients With Dry Eye Syndrome","status":"COMPLETED","sponsor":"Dhp Korea Co., Ltd.","startDate":"2008-11","conditions":"Dry Eye Syndromes, Keratoconjunctivitis Sicca","enrollment":72}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":9,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["DHP-101"],"phase":"phase_2","status":"active","brandName":"AT01","genericName":"AT01","companyName":"Dhp Korea Co., Ltd.","companyId":"dhp-korea-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"AT01 is a small molecule that targets the SGLT2 receptor. Used for Type 2 diabetes.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}